The University of Chicago Header Logo

Connection

Janardan Khandekar to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications Janardan Khandekar has written about Antimetabolites, Antineoplastic.
Janardan Khandekar
Connection Strength
0.016
Antimetabolites, Antineoplastic
  1. Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma. Cancer Invest. 2007 Aug; 25(5):366-71.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.